The effect of magnesium supplementation on depressio

Phase 2

Conditions: Depression.
F32, F33
most of
This block contains disorders in which the fundamental disturbance is a change in affect or mood to depression (with or without associated anxiety) or to elation. The mood change is usually accompanied by a change in the overall level of activity

Registration Number: IRCT2013121015744N1

Lead Sponsor: Research Council (Research and Technology) of Shahid Sadooghi University of Medical Sciences and Hea

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 600

Inclusion Criteria

people aged 20-60 years old and depression is diagnosed by a psychiatrist; not suffering from disorders and diseases of the kidney, liver, heart, thyroid, bleeding disorders and malignancies; non- degenerative disease autoimmune; non- autoimmune degenerative diseases; lack of central nervous system diseases; no history of mental illness; lack of food; lack of consumption of antidepressants and diuretics during the last 3 months pregnant and not lactating and non- events include loss of job; divorce; death of first-degree relatives in the past 3 months and have not participated in other research projects that self -reporting of this information will be recorded. Exclusion criteria: people who are not more than 20 % of the drug; while studying people who start taking a multivitamin and mineral supplement may have changed who have created the drug are.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression. Timepoint: Before the intervention, and three months after intervention. Method of measurement: Beck Depression Inventory.;Serum magnesium. Timepoint: Three months after the intervention, but intervention. Method of measurement: Serum magnesium test.

Secondary Outcome Measures